NewGenIvf Group Ltd is a tech-forward, diversified, multi-jurisdictional entity capitalizing on emerging opportunities across real estate development, digital asset innovation, and reproductive health solutions. The company offers two services, namely: in vitro fertilization (IVF) treatment service, comprising traditional IVF and egg donation; and fertility referral services, like surrogacy and ancillary caring services. It derives maximum revenue from in vitro fertilization (IVF) treatment service. Its Geographical presence is in China / HK SAR, Thailand, Cambodia, U.S and Kyrgyzstan. The company derives maximum revenue from Kyrgyzstan.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 4 | 3,722,223 | $4.16M |
| Grant or award | 4 | 691,574 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
13 Form 4 filings on record, the earliest from May 6, 2026, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Kong Yiu Cheung - Director | Open-market purchase | Class A Ordinary Shares | 222,223 | $13.50 | $333K | |
| Kong Yiu Cheung - Director | Open-market purchase | Class A Ordinary Shares | 500,000 | $11.97 | $665K | |
| Kong Yiu Cheung - Director | Open-market purchase | Class A Ordinary Shares | 500,000 | $11.97 | $665K | |
| Kong Yiu Cheung - Director | Open-market purchase | Class A Ordinary Shares | 2,500,000 | $3.00 | $2.50M | |
| Grant or award | Stock Options (Right to Buy) | 272,140 | $0.00 | - | ||
| Wing Fung Alfred Siu - Officer | Grant or award | Stock Options (Right to Buy) | 272,140 | $0.00 | - | |
| Wing Fung Alfred Siu - Director | Grant or award | Employee Share Options | 73,647 | $0.00 | - | |
| Grant or award | Employee Share Options | 73,647 | $0.00 | - | ||
| HRT FINANCIAL LP - 10% Owner | Open-market sale | Common Stock | 64,945 | $7.03 | $51K | |
| Wing Fung Alfred Siu - Director | Option exercise | Class B Ordinary Shares | 56,851 | $0.00 | $6 | |
| Option exercise | Class B Ordinary Shares | 56,851 | $0.00 | $6 | ||
| HRT FINANCIAL LP - 10% Owner | Open-market purchase | Common Stock | 23,018 | $8.50 | $22K | |
| HRT FINANCIAL LP - 10% Owner | Open-market purchase | Common Stock | 11,738 | $7.88 | $10K | |
| HRT FINANCIAL LP - 10% Owner | Open-market sale | Common Stock | 85,317 | $7.20 | $68K | |
| HRT FINANCIAL LP - 10% Owner | Open-market purchase | Common Stock | 137,541 | $8.91 | $136K | |
| HRT FINANCIAL LP - 10% Owner | Open-market purchase | Common Stock | 27,993 | $8.28 | $26K | |
| Wing Fung Alfred Siu - Officer | Grant or award | Stock Options (Right to Buy) | 56,851 | $0.00 | - | |
| Grant or award | Stock Options (Right to Buy) | 56,851 | $0.00 | - |
NewGenIvf Group Ltd (NIVF) had 5 insider filings in the last 90 days, with the most recent on 2026-09-02. The full record for NIVF runs to 13 Form 4 filings, the earliest from 2026-05-06. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
4 insider purchases of NIVF were filed in the last 90 days, totaling $4.16M.
No insider sales of NIVF were filed in the last 90 days. 2 sales are on record for this company.
This page tracks NIVF Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add NIVF to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.